Diagnostic value of histamine and tryptase concentrations in severe anaphylaxis with shock or cardiac arrest during anesthesia

Anesthesiology

Volumn 121, Issue 2, 2014, Pages 272-279

  Laroche, Dominique ^a   Gomis, Philippe ^b   Gallimidi, Emmanuel ^c   Malinovsky, Jean Marc ^d   Mertes, Paul Michel ^e  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b HÔPITAL MAISON BLANCHE   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

^d UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^e UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; TRYPTASE;

ADULT; ALLERGIC REACTION; ALLERGY TEST; ANESTHESIA; ARTICLE; CARDIOGENIC SHOCK; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME BLOOD LEVEL; FEMALE; HEART ARREST; HISTAMINE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RESUSCITATION; SENSITIVITY AND SPECIFICITY; SEPTIC SHOCK; SHOCK;

ADULT; AGED; ANAPHYLAXIS; ANESTHESIA; AREA UNDER CURVE; DRUG HYPERSENSITIVITY; FEMALE; HEART ARREST; HISTAMINE; HISTAMINE RELEASE; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; ROC CURVE; SAMPLE SIZE; SHOCK; TRYPTASES;

EID: 84904968250     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000276     Document Type: Article

References (32)

1. Simons FER, Ardusso LRF, Bilo MB, El-Gamal YM, Ledford DK, Ring J, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY: World Allergy Organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011; 4:13-37
2. Johansson SGO, OB Hourihane J, Bousquet J, Bruijnzeel- Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, van Hage-Hamsten M, Wüthrich B: A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56:813-24.
3. Laroche D, Vergnaud MC, Sillard B, Soufarapis H, Bricard H: Biochemical markers of anaphylactoid reactions to drugs. Comparison of plasma histamine and tryptase. Anesth esiology 1991; 75:945-9
4. Halmerbauer G, Hauk P, Forster J, Urbanek R, Kaufmehl K, Koller DY: In vivo histamine release during the first minutes after deliberate sting challenges correlates with the severity of allergic symptoms. Pediatr Allergy Immunol 1999; 10:53-7
5. Laroche D, Dubois F, Gérard JL, Lefranois C, André B, Vergnaud MC, Dubus L, Bricard H: Radioimmunoassay for plasma histamine: A study of false positive and false negative values. Br J Anaesth 1995; 74:430-7
6. Schwartz LB: Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am 2006; 26:451-63
7. Watkins J: Tryptase release and clinical severity of anaesthetic reactions. Agents Actions 1992; 36:C203-205
8. Fisher MM, Baldo BA: Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 1998; 80:26-9
9. Schwartz LB, Bradford TR, Rouse C, Irani AM, Rasp G, Van der Zwan JK, Van der Linden PW: Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis. J Clin Immunol 1994; 14: 190-204
10. Schwartz LB, Sakai K, Bradford TR, Ren S, Zweiman B, Worobec AS, Metcalfe DD: The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. J Clin Invest 1995; 96:2702-10
11. Sperr WR, Jordan JH, Baghestanian M, Kiener HP, Samorapoompichit P, Semper H, Hauswirth A, Schernthaner GH, Chott A, Natter S, Kraft D, Valenta R, Schwartz LB, Geissler K, Lechner K, Valent P: Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood 2001; 98:2200-9
12. Laxenaire MC: Reducing the risk of anaphylaxis during anaesthesia. Abbreviated text. Rev Fr Allergol Immunol Clin 2002; 42:650-65
13. Lever A, Mackenzie I: Sepsis: Definition, epidemiology, and diagnosis. BMJ 2007; 335:879-83
14. Mertes PM, Laxenaire MC; Les membres du GERAP: Anaphylactic and anaphylactoid reactions occurring during anaesthesia in France. Seventh epidemiologic survey (January 2001-December 2002). Ann Fr Anesth Réanim 2004; 23:1133-43 (French)
15. Mertes PM, Laxenaire MC, Lienhart A, Aberer W, Ring J, Pichler WJ, Demoly P; Working Group for the SFAR; ENDA; the EAACI Interest Group on Drug Hypersensitivity: Reducing the risk of anaphylaxis during anesthesia. Guidelines for clinical practice. J Invest Allergol Clin Immunol 2005; 15: 91-101
16. Ring J, Messmer K: Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1: 466-9
17. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36
18. DeLong ER, DeLong DM, Clarke-Pearson DL: Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 1988; 44:837-45
19. Mertes PM, Alla F, Tréchot P, Auroy Y, Jougla E; Groupe dEtudes des Réactions Anaphylactodes Peranesthésiques: Anaphylaxis during anesthesia in France: An 8-year national survey. J Allergy Clin Immunol 2011; 128: 366-73
20. Dong SW, Mertes PM, Petitpain N, Hasdenteufel F, Malinovsky JM; Members of the GERAP: Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007). Minerva Anestesiologica 2012; 78: 868-78
21. Ludolph-Hauser D, Ruëff F, Fries C, Schöpf P, Przybilla B: Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings. Lancet 2001; 357:361-2
22. Garvey LH, Bech B, Mosbech H, Krigaard M, Belhage B, Husum B, Poulsen LK: Effect of general anesthesia and orthopedic surgery on serum tryptase. Anesth esiology 2010; 112:1184-9
23. Genovese A, Stellato C, Marsella CV, Adt M, Marone G: Role of mast cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media. Int Arch Allergy Immunol 1996; 110:13-22
24. Malinovsky JM, Decagny S, Wessel F, Guilloux L, Mertes PM: Systematic follow-up increases incidence of anaphylaxis during adverse reactions in anesthetized patients. Acta Anaesthesiol Scand 2008; 52:175-81
25. Enrique E, García-Ortega P, Sotorra O, Gaig P, Richart C: Usefulness of UniCAP-Tryptase fluoroimmunoassay in the diagnosis of anaphylaxis. Allergy 1999; 54:602-6
26. Brown SG, Blackman KE, Heddle RJ: Can serum mast cell tryptase help diagnose anaphylaxis? Emerg Med Australas 2004; 16:120-4
27. Borer-Reinhold M, Haeberli G, Bitzenhofer M, Jandus P, Hausmann O, Fricker M, Helbling A, Müller U: An increase in serum tryptase even below 11.4 ng/mL may indicate a mast cell-mediated hypersensitivity reaction: A prospective study in Hymenoptera venom allergic patients. Clin Exp Allergy 2011; 41:1777-83
28. Lin RY, Schwartz LB, Curry A, Pesola GR, Knight RJ, Lee HS, Bakalchuk L, Tenenbaum C, Westfal RE: Histamine and tryptase levels in patients with acute allergic reactions: An emergency department-based study. J Allergy Clin Immunol 2000; 106(1 Pt 1):65-71
29. Edston E, Eriksson O, van Hage M: Mast cell tryptase in postmortem serum-reference values and confounders. Int J Legal Med 2007; 121:275-80
30. Way MG, Baxendine CL: The significance of post mortem tryptase levels in supporting a diagnosis of anaphylaxis. Anaesthesia 2002; 57:310-1
31. Farnam K, Chang C, Teuber S, Gershwin ME: Nonallergic drug hypersensitivity reactions. Int Arch Allergy Immunol 2012; 159:327-45
32. Fisher M, Baldo BA: Anaphylaxis during anesthesia: Current aspects of diagnosis and prevention. Eur J Anaesth 1994; 11:263-84